Literature DB >> 8930949

Herpes simplex virus type 1 encephalitis in acquired immunodeficiency syndrome.

F Chrétien1, L Bélec, D A Hilton, M Flament-Saillour, F Guillon, L Wingertsmann, M Baudrimont, P de Truchis, C Keohane, C Vital, S Love, F Gray.   

Abstract

Herpes simplex (HSV) infection of the central nervous system is uncommon in AIDS and usually has an atypical topography. This review is centred around the case of a 49-year-old homosexual patient with AIDS who died from diffuse encephalopathy. Neuropathological examination revealed necrotic and haemorrhagic changes involving both temporal lobes, insulae and cingulate gyri. Cowdry type A intranuclear inclusion bodies were abundant but inflammation was minimal. Electron microscopy confirmed characteristic herpes virus particles. Immunocyto-chemistry was positive for HSV type 1 and 2. In situ hybridization and PCR, however, were positive for HSV type 1 but excluded HSV type 2. There was associated cytomegalovirus ventriculitis but clearly separated from HSV encephalitis. There were no histological features of HIV encephalitis and HIV could not be demonstrated by immunocytochemistry or by PCR to demonstrate proviral DNA. Apoptotic neurons were numerous in areas with a severe macrophage reaction. Only two pathological cases with characteristic limbic distribution and necrotic haemorrhagic histologic have been reported previously. The rarity of these reports suggests that in advanced AIDS, the immune reaction causing a typical necrotizing encephalitis cannot be mounted. Distinction between HSV type 1 and 2 infection may be difficult by immunocytochemistry and usually requires in situ hybridization, tissue culture or PCR. In AIDS patients, HSV-1 has been identified as responsible for encephalitis whereas HSV-2 has been more responsible for myelitis. Associated productive HIV infection of the CNS was found in none of the cases. In contrast, cytomegalovirus encephalitis was found in nine of 11 cases of AIDS-associated HSV encephalitis.

Entities:  

Mesh:

Year:  1996        PMID: 8930949     DOI: 10.1111/j.1365-2990.1996.tb00909.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

Review 1.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

2.  2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Authors:  Mårten Strand; Koushikul Islam; Karin Edlund; Christopher T Oberg; Annika Allard; Tomas Bergström; Ya-Fang Mei; Mikael Elofsson; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

3.  Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

Authors:  Lbachir BenMohamed; Georges Bertrand; Cory D McNamara; Helene Gras-Masse; Juergen Hammer; Steven L Wechsler; Anthony B Nesburn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 4.  Special populations: the management of seizures in HIV-positive patients.

Authors:  Paul Mullin; Gary Green; Rohit Bakshi
Journal:  Curr Neurol Neurosci Rep       Date:  2004-07       Impact factor: 5.081

5.  Serial proton MR spectroscopy and diffusion imaging findings in HIV-related herpes simplex encephalitis.

Authors:  Philipp G Sämann; Jürgen Schlegel; Georg Müller; Franz Prantl; Christoph Emminger; Dorothee P Auer
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

Review 6.  Central nervous system infections: a critical care approach.

Authors:  W C Ziai; R G Geocadin
Journal:  Curr Neurol Neurosci Rep       Date:  2001-11       Impact factor: 6.030

7.  Enzyme-assisted extraction of bioactive material from Chondrus crispus and Codium fragile and its effect on herpes simplex virus (HSV-1).

Authors:  Garima Kulshreshtha; Anne-Sophie Burlot; Christel Marty; Alan Critchley; Jeff Hafting; Gilles Bedoux; Nathalie Bourgougnon; Balakrishnan Prithiviraj
Journal:  Mar Drugs       Date:  2015-01-16       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.